| Abstral™ is indicated for the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain
(Dibasic Sodium Phosphate Monobasic Sodium Phosphate Calcium Chloride )
| Caphosol® is indicated for dryness of the mouth and oropharynx (hyposalivation, xerostomia), regardless of the cause and regardless of whether the condition is temporary or permanent. Caphosol® is also indicated as an adjunct to standard oral care in the prevention and treatment of the mucositis that may be caused by radiation or high dose chemotherapy. Relief of dryness of the oral mucosa in these conditions is associated with amelioration of pain.
(fentanyl citrate nasal spray, solution)
| PecFent® is indicated for the management of breakthrough pain in adults who are already receiving maintenance opioid therapy for chronic cancer pain.
(granisetron transdermal patch)
| SANCUSO transdermal patch is indicated in adults for the prevention of nausea and vomiting associated with moderately or highly emetogenic chemotherapy, for a planned duration of
3 to 5 consecutive days, where oral anti-emetic administration is complicated by factors making swallowing difficult